Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommended tool compounds and drugs for blocking P2X and P2Y receptors
Christa E. Müller, Vigneshwaran Namasivayam
Purinergic Signalling (2021) Vol. 17, Iss. 4, pp. 633-648
Open Access | Times Cited: 36

Showing 26-50 of 36 citing articles:

Structural insights into the allosteric inhibition of P2X4 receptors
Cheng Shen, Wenwen Cui, Yu‐Qing Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
The Potential of Purinergic Signaling to Thwart Viruses Including SARS-CoV-2
Davide Ferrari, Michele Rubini, Jorge S. Burns
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Targeting Nuclear Receptors for Chronic Inflammatory Pain: A Potential Alternative
Kristine Griffett
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 6, pp. 440-444
Open Access | Times Cited: 3
Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism
Rua'a Al‐Aqtash, Daniel M. Collier
Channels (2024) Vol. 18, Iss. 1
Open Access
Recent advances in the development of P2Y 14 R inhibitors: a patent and literature review (2018-present)
Kai Wang, Fen Zhong, Zhou-Dong Zhang, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 611-625
Closed Access
Overview of the role of purinergic signaling and insights into its role in cancer therapy
Francesco Di Virgilio, Valentina Vultaggio-Poma, Mario Tarantini, et al.
Pharmacology & Therapeutics (2024) Vol. 262, pp. 108700-108700
Open Access
Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes
Guillermo A. Cabral-García, José R. Cruz-Muñoz, Eduardo E. Valdez-Moráles, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1291-1291
Open Access
Treatment of Complex Regional Pain Syndrome (CRPS): New Perspectives in the use of Sulfonamides as Modulators of P2X Receptors
Giulia Culletta, Anna Maria Almerico, Marco Tutone
Recent Advances in Inflammation & Allergy Drug Discovery (2023) Vol. 17, Iss. 2, pp. 88-95
Open Access | Times Cited: 1
Call for Manuscripts for ACS Pharmacology & Translational Science Review Series on Recommended Tool Compounds
Christa E. Müller
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 8, pp. 516-517
Open Access | Times Cited: 2
Delineating Purinergic Signaling in Drosophila
Cinzia Volonté, Francesca Alberti, Giuseppe Vitale, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15196-15196
Open Access | Times Cited: 1
Extracellular Binding Sites of Positive and Negative Allosteric P2X4 Receptor Modulators
Stephanie Weinhausen, Jessica Nagel, Vigneshwaran Namasivayam, et al.
SSRN Electronic Journal (2022)
Closed Access
Previous Page - Page 2

Scroll to top